SEC Company Response from Paranovus Entertainment Technology Ltd. (PAVS) (CIK 0001751876) (PAVS) — Jun 26, 2019
Paranovus Entertainment Technology Ltd. (PAVS) (CIK 0001751876)
Date: June 26, 2019 · CIK: 0001751876 · Accession: 0001213900-19-011526
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-230170
Letter
VIA EDGAR Re: Happiness Biotech Group Ltd Registration Statement on Form F-1 Initially Filed March 8, 2019 File No. 333-230170
Dear Ms. Breslin:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Happiness Biotech Group Ltd hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time on June 28, 2019, or as soon as thereafter practicable.
Please note that we acknowledge the following:
● should the Securities and Exchange Commission (the “Commission”) or the staff (the “Staff”), acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
● the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
● the Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
/s/
Bian Jiong
Show Raw Text
CORRESP
1
filename1.htm
Happiness Biotech Group Limited
No. 11, Dongjiao East Road, Shuangxi,
Shunchang, Nanping City
Fujian Province, China
VIA EDGAR
June 26, 2019
U.S. Securities and Exchange Commission
100 F Street, N.E.
Mail Stop 3233
Washington, D.C. 20549
Attn: Mary Beth Breslin
Re:
Happiness Biotech Group Ltd
Registration Statement on Form F-1
Initially Filed March 8, 2019
File No. 333-230170
Dear Ms. Breslin:
Pursuant to Rule 461
under the Securities Act of 1933, as amended, Happiness Biotech Group Ltd hereby requests acceleration of effectiveness of the
above referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time on June 28, 2019, or as soon
as thereafter practicable.
Please note that we
acknowledge the following:
● should the Securities and Exchange Commission (the “Commission”)
or the staff (the “Staff”), acting pursuant to delegated authority, declare the filing effective, it does not foreclose
the Commission from taking any action with respect to the filing;
● the action of the Commission or the Staff, acting pursuant to delegated
authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy
of the disclosure in the filing; and
● the Company may not assert Staff comments and the declaration of effectiveness
as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
/s/
Bian Jiong
Bian Jiong
Chief Financial Officer